Recombinant CD47 (Magrolimab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) 抗体 (ABIN7597807)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Research Grade Magrolimab Biosimilar Antibody
-
特异性
- Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6
-
纯化方法
- Protein A or G purified from cell culture supernatant.
-
纯度
- >95 % by SDS-PAGE.
-
亚型
- IgG4 kappa
-
-
anti-CD47 (Magrolimab Biosimilar) antibody
Research Grade 适用: 人 ELISA, FACS 宿主: Humanized Mouse Chimeric unconjugated Recombinant Antibody
anti-CD47 (Magrolimab Biosimilar) antibodyResearch Grade 适用: 人 ELISA, FACS 宿主: Human Monoclonal unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 3.65 mg/mL
-
缓冲液
- 0.01M PBS, pH 7.4.
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
有效期
- 12 months
-
-
- CD47 (Magrolimab Biosimilar)
-
别名
- Magrolimab Biosimilar
-
物质类
- Biosimilar
-
背景
- Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6
-
UniProt
- Q08722
-
CAS-编号
- 2169232-81-7
抗原
-
